Clinical Trials
2 trialsNCT04812509 2023-02-24
Efficacy and Safety of MW032 and Xgeva® in Subjects With Bone Metastases From Solid Tumors
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 3 Completed
NCT01106352 2017-01-04
A Study of Alpharadin With Docetaxel in Patients With Bone Metastasis From Castration-Resistant Prostate Cancer (CRPC)
Bayer
Phase 1/2 Completed